CD44 and breast cancer: A decade ago, the isolation of tumorigenic breast cancer cells with the phenotype CD44+CD24−/low represented a first step towards the characterization of breast CSCs [14], which was complemented soon after with the discovery of their capacity to grow as mammospheres [69] and their enhanced aldehyde dehydrogenase activity [13].